| Affiliation: | 1. Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany;2. Translational Epigenetics Group, Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany;1. Gregor Mendel Institute (GMI), Austrian Academy of Sciences, Vienna BioCenter (VBC), Dr. Bohr Gasse 3, 1030 Vienna, Austria;2. Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, A-1030, Vienna, Austria;1. Division of Gene Regulation and Oncode Institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands;2. Department of Cell Biology, Erasmus University Medical Center, Rotterdam;1. MRC London Institute of Medical Sciences, Du Cane Road, London, W12 0NN, UK;2. Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK;3. Max Planck Institute for Molecular Biomedicine, Münster, Germany;1. Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA;2. Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA;3. Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA;1. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 17165, Sweden;2. Science for Life Laboratory, Solna, 17165, Sweden |
